Literature DB >> 2403027

Allopurinol add-on treatment in intractable seizures.

F Marrosu1, G Marrosu, M G Rachele, C Masala, M Giagheddu.   

Abstract

Recent reports in clinical literature have suggested an antiepileptic effect of the xanthine oxidase inhibitor Allopurinol (ALL) when added to traditional drugs. However, other reports have failed to confirm beneficial effects of this drug. In view of these conflicting results, we have carried out a study aimed at evaluate the effects of ALL in different forms of epilepsy. The result that ALL possesses some antiepileptic effects in Lennox-Gastaut syndromes, characterized by numerous and severe fits, while it is scarcely effective in other forms of epilepsy, suggests that ALL might be involved in the purinergic-mediated inhibition similar to that described in experimental "status epilepticus" studies in animal models.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403027

Source DB:  PubMed          Journal:  Acta Neurol (Napoli)        ISSN: 0001-6276


  3 in total

Review 1.  A risk-benefit assessment of therapies for Lennox-Gastaut syndrome.

Authors:  D Schmidt; B Bourgeois
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

2.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

Review 3.  Role of oxidative stress in refractory epilepsy: evidence in patients and experimental models.

Authors:  Noemi Cardenas-Rodriguez; Bernardino Huerta-Gertrudis; Liliana Rivera-Espinosa; Hortencia Montesinos-Correa; Cindy Bandala; Liliana Carmona-Aparicio; Elvia Coballase-Urrutia
Journal:  Int J Mol Sci       Date:  2013-01-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.